Pharmacology for Obesity Management Flashcards

1
Q

Why use pharmacology for management? ( 3)

A
  1. improvements in obesity related comorbidities
  2. behaviour changes alone only target 3-5% weight loss, which is not often sustained over long term
  3. pharmacology can facilitate weight management & optimize health
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

medications approved in Canada (4) + their average weight loss % in one year

A
  1. Orlistat (-10.2%= 4% BF lost)
  2. Liraglutide (-8.6%= 6% BF lost)
  3. naltrexone/bupropion (-6.1%=5% BF lost)
  4. semaglutide (-14.9%= 12% BF lost)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

how medication acts on the body (4)

A
  1. Acts of the hypothalamus
  2. slows stomach emptying (CHO absorption is prolonged)
  3. reduces glucose production in the liver & increases uptake in sk. muscle
  4. raises insulin & lowers glucagon secretion after eating (results in improved insulin sensitivity)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what is the goal of treatment with medication?

A

To decrease the fat mass set point & re-regulate physiology. As set point decreases/resets so does weight loss.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Many medications work in the brain through neural mechanisms, which medication does not ?

A

Orlistat. And it does not impact the set point

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Factors that drive up set points (environmental & genetic)

A
  1. various environmental factors
    -diet
    -unhealthy muscle
    -sleep deprivation
    -distruped carcadian rhythm
    -sed. behaviour
    -weight gain inducinh medications used to treat other diseases
  2. Genetic factors
    -hormones signals to the brain to let it know our energy state
    -body determines what we eat, how much, when & what we crave.
    -The brain determines & regulates the body fat mass set point
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

clinical considerations with pharmacology treatments

A

-it is intended to be long term & response to treatment will vary by individual
-identify individual goals of therapy prior to initiating
-set reasonable expectations & time required to see benefits

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

targets of treatment (5)

A

-weight loss
-improvement in health parameters not soley weight reduction
-weight maintenence in health parameters
-control cravings
-improvement in quality of life

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

other considerations for the use of pharmacology (9)

A
  1. goals of therapy
  2. patient values & preferences
  3. patient co morbidities
  4. mechanism of action
  5. side effects/tolerability
  6. safety
  7. existing medications
  8. mode & frequency of administration
  9. cost
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

common side effects: semaglutide

A

nausea, vomitting, diarrhea & constipation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

common side effects: Liraglutide

A

nausea, vomitting, diarrhea & constipation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

common side effects: Naltrexone/bupropion

A

nausea, vomitting, diarrhea & constipation, headache, drymouth, dizzy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

common side effects: Orlistat

A

loose, oily stools & flatus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

semaglutide as a treatment (4)

A
  1. an effective approach to treating obesity
  2. focus should be on improving health parameters > soley weight reduction
  3. intended as part of a long term strategy
  4. demonstrates higher efficacy than any other previously approved anti-obesity med. Effects on lean body mass have not been studied
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what is bariatric surgery

A

gastrointestinal surgical intervention conducted to produce sustainable weight loss

  • currently the best theraputic modality that can truely claim to produce sustainable weight loss
17
Q

who qualifies for bariatric surgey?

A
  1. BMI >40 (class 3)
  2. BMI >35 (class 2) & severe weight related co-morbidities
  3. BMI >30 (class 1) if coupled w/ T2D may be considered
18
Q

other eligabilities for bariatric surgery (4)

A

-pre op testing & consult
- mentally & emotionally prepared
-support system in place
-committed to life long adherence

19
Q

eligabilities for anti obesity medications

A
  1. BMI >30
    OR
  2. BMI >27 with comorbidities
20
Q

what is gastric sleeve surgery

A

-restrictive intervention
-longitudinal resection of the stomach. Takes out 85% of stomach.
-reduces functional capacity of the stomach & eliminates the ghrelin rich gastric fluids
-results in 33% weight loss per year
-small capacity/resistant to stretching

21
Q

what is Roux en Y gastric bypass

A

-combination intervention
-Ingested food by passes 95% of the stomach
-entire duodenum & portion of jejunum
-limited nutrient absorption, have to take supplements (B Vit & iron) for the rest of your life
-Probably not ideal if you are looking to get pregnant
-low ability to cheat (drink their calories)
-good surgery for food addictions due to malabsorption of nutrients

22
Q

what is Biliopancreatic Diversion surgery

A

-combination intervention
-less common & more risky. Prone to serious malnutrition & deficiences
-stomach & small intestine surgically reduced so nutrients absorbed only in50cm common limb

23
Q

gastric bypass: pro (6)

A

-covered by MSP
-average weight loss is 75% of excess weight
-weigt loss occurs rapidly in first 12 months
-96% of associated health conditions are improved
-early & late complication rates are low
-patient returns to eating normal but at low quantities

24
Q

Gastric bypass: cons (5)

A

-poor absorption of iron & calcium due to by passed duodenum
-no iron/calcium can lead to anemia
-vitamin B12 deficiency may occur
-Women should be careful since they are already at risk for osteoporosis
-Dumping syndrome: due to rapid emptying of the stomach into small intestine (triggered with too much sugar/food)
-ulcers/bleeding may occur if poor vision while in surgery

25
Q

typical patient for bypass surgery

A

women in her 40’s who has obesity & other conditions

26
Q

risks of bariatric surgery (3)

A

-complications & readmission rates have decreased and are rare
-complications are less than hip surgery
-readmission rates are similar for surgical patients all over canada

27
Q

non fatal (general) complications with bariatric surgery (9)

A

-dumping syndrome
-vitamin/mineral deficiency
-vomitting/nausea
-staple line fracture
-infection
-stenosis/bowel obstruction
-ulceration
-bleeding
-splenic surgery

28
Q

benefits of bypass surgery

A

-reduces onset diabetes
-remission of existing diabetes
-lower mortality rate

29
Q

what to consider when thinking about bypass surgery? (5)

A
  1. accessibility
  2. expectations
  3. psychological impact? (marriage, relationships can be neg. impacted)
  4. post operative plastic surgery (remove extra skin)
  5. side effects (expected/unexpected)